Literature DB >> 15276466

Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart.

Salvatore Pepe1, Olivier W V van den Brink, Edward G Lakatta, Rui-Ping Xiao.   

Abstract

Opioid peptide receptor (OPR) and beta-adrenergic receptor (beta-AR) are well-established members of G-protein-coupled receptor (GPCR) superfamily and are involved in regulating cardiac contractility, energy metabolism, myocyte survival or death. OPRs are typical Gi/Go-coupled receptors and activated by opioid peptides derived from the endorphin, dynorphin and enkephalin families, whereas beta-AR stimulated by catecholamines is the model system for Gs-coupled receptors. While it is widely accepted that beta-AR stimulation serves as the most powerful means to increase cardiac output in response to stress or exercise, we have only begun to appreciate functional roles of OPR stimulation in regulating cardiovascular performance. Cardiovascular regulatory effects of endogenous opioids were initially considered to originate from the central nervous system and involved the pre-synaptic co-release of norepinephrine with enkephalin from sympathetic neuronal terminals in the heart. However, opioid peptides of myocardial origin have been shown to play important roles in local regulation of the heart. Notably, OPR stimulation not only inhibits cardiac excitation-contraction coupling, but also protects the heart against hypoxic and ischemic injury via activation of Gi-mediated signalling pathways. Further, OPRs functionally and physically cross-talk with beta-ARs via multiple hierarchical mechanisms, including heterodimerization of these receptors, counterbalance of functional opposing G protein signalling, and interface at downstream signalling events. As a result, the beta-AR-mediated positive inotropic effect and increase in cAMP are markedly attenuated by OPR activation in isolated cardiomyocytes as well as sympathectomized intact rat hearts. This brief review will focus on the interaction between beta-AR and OPR and its potential physiological and pathophysiological relevance in the heart. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276466     DOI: 10.1016/j.cardiores.2004.04.022

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  24 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

2.  Inhibitory effects of landiolol and nicardipine on thiopental-induced yawning in humans.

Authors:  Tsutomu Oshima; Tatsuo Murakami; Yuhji Saitoh; Miyuki Yokota; Yoshiko Kasuya
Journal:  J Anesth       Date:  2010-02-20       Impact factor: 2.078

3.  Prolonged Morphine Treatment Alters Expression and Plasma Membrane Distribution of β-Adrenergic Receptors and Some Other Components of Their Signaling System in Rat Cerebral Cortex.

Authors:  Lucie Hejnova; Jitka Skrabalova; Jiri Novotny
Journal:  J Mol Neurosci       Date:  2017-10-28       Impact factor: 3.444

4.  Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Authors:  Aaron M Firoved; Georgina F Miller; Mahtab Moayeri; Rahul Kakkar; Yuequan Shen; Jason F Wiggins; Elizabeth M McNally; Wei-Jen Tang; Stephen H Leppla
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 5.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

6.  Effect of U50,488H, a κ-opioid receptor agonist on myocardial α-and β-myosin heavy chain expression and oxidative stress associated with isoproterenol-induced cardiac hypertrophy in rat.

Authors:  Amardeep Jaiswal; Santosh Kumar; Sandeep Seth; Amit Kumar Dinda; Subir Kumar Maulik
Journal:  Mol Cell Biochem       Date:  2010-08-21       Impact factor: 3.396

7.  Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats.

Authors:  Sascha Treskatsch; Mohammed Shaqura; Lukas Dehe; Torsten K Roepke; Mehdi Shakibaei; Michael Schäfer; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-12-19       Impact factor: 2.037

8.  Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats.

Authors:  Sascha Treskatsch; Aarne Feldheiser; Mohammed Shaqura; Lukas Dehe; Helmut Habazettl; Torsten K Röpke; Mehdi Shakibaei; Michael Schäfer; Claudia D Spies; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-01-01       Impact factor: 2.037

9.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

10.  Unexpected amplification of leptin-induced Stat3 signaling by urocortin: implications for obesity.

Authors:  Weihong Pan; Hong Tu; Hung Hsuchou; Jeremy Daniel; Abba J Kastin
Journal:  J Mol Neurosci       Date:  2007-09-05       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.